As Expected: Shareholders Back Bristol's $74bn Celgene Buy

 
• By Mandy Jackson
  
Yes-No
Bristol and Celgene shareholders endorsed their merger April 12. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business